Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
In addition to their role in controlling water and salt homeostasis, recent work suggests that aldosterone and mineralocorticoid receptors (MR) may be involved in adipocyte biology. This is of particular relevance given the role of MR as a high‐affinity receptor for both mineralocorticoids and glucocorticoids. We have thus examined the effect of aldosterone and MR on white adipose cell differentiation. When cells are cultured in a steroid‐free medium, aldosterone promotes acquisition of the adipose phenotype of 3T3‐L1 and 3T3‐F442A cells in a time‐, dose‐, and MR‐dependent manner. In contrast, late and long‐term exposure to dexamethasone inhibits adipocyte terminal maturation. The aldosterone effect on adipose maturation was accompanied by induction of PPARγ mRNA expression, which was blocked by the MR antagonist spironolactone. Under permissive culture conditions, specific MR down‐regulation by siRNAs markedly inhibited 3T3‐L1 differentiation by interfering with the transcriptional control of adipogenesis, an effect not mimicked by specific inactivation of the glucocorticoid receptor. These results demonstrate that MR represents an important proadipogenic transcription factor that may mediate both aldosterone and glucocorticoid effects on adipose tissue development. MR thus may be of pathophysiological relevance to the development of obesity and the metabolic syndrome.–Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., Zennaro, M‐C. Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis. FASEB J. 21, 2185–2194 (2007)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aldosterone increases pre-adipocyte differentiation tissue in vivo (39)”
From Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans (2020) · cites this paper as [39]
In the citing paper
“The adipocyte MRs may mediate a proadipogenic effect of both aldosterone () and GCs ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [175]
In the citing paper
“MRs on adipocytes promoted the expression of inflammatory adipokines (-), giving rise to lower insulin receptor expression and impaired insulin-induced glucose uptake ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [175]
Citations
Cites
1 retracted
Kitagawa, H., Yanagisawa, J., Fuse, H., Ogawa, S., Yogiashi, Y., Okuno, A., Nagasawa, H., Nakajima, T., Matsumoto, T., & Kato, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3698-3706.2002 · Cited by 101 · cited 1×
“This would not be surprising, since aldosterone and glucocorticoids have been shown to recruit different coregulators to MR-responsive promoters, thus differentially affecting gene transcription (24).”
BackgroundRetractedStimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
Understanding Adipocyte Differentiation
GREGOIRE, F. M., SMAS, C. M., & SUL, H. S. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.3.783 · Cited by 2,376 · cited 2×
“To better elucidate the mechanism of aldosterone action, we asked whether its proadipogenic effects were reproduced in 3T3-F442A cells, which are generally regarded as a model with a more advanced commitment in the adipose differentiation process (1); consistent with this, 3T3-F442A cell differentiation is independent…”
BackgroundArriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946 · cited 2×
“Exposure to aldosterone for 7 days was accompanied by a dose-dependent increase in cell triglyceride accumulation and G3PDH activity (Fig. 3C), with an EC50 value between 0.3 and 0.6 nM, consistent with the affinity of the MR for aldosterone ( 7 ).”
BackgroundInfluentialTranscriptional regulation of adipogenesis
Rosen, E. D., Walkey, C. J., Puigserver, P., & Spiegelman, B. M. (2000) · Genes & Development · doi:10.1101/gad.14.11.1293 · Cited by 1,898 · cited 1×
“It is generally recognized that C/EBP is involved early and transiently in the control of adipogenesis, while PPAR and C/EBP are involved more distally (26), and that expression of the relevant genes is regulated in a sequential and coordinated manner by environmental proadipogenic factors.”
BackgroundLacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 3×
“In vivo, convincing evidence exists for a major role of glucocorticoids on adipose differentiation, as elegantly demonstrated in transgenic animal models (2).”
BackgroundC/EBPα induces adipogenesis through PPARγ: a unified pathway
Rosen, E. D., Hsu, C.-H., Wang, X., Sakai, S., Freeman, M. W., Gonzalez, F. J., & Spiegelman, B. M. (2002) · Genes & Development · doi:10.1101/gad.948702 · Cited by 1,494 · cited 1×
“sufficient to promote adipogenesis (27).”
Newell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network
Bookout, A. L., Jeong, Y., Downes, M., Yu, R. T., Evans, R. M., & Mangelsdorf, D. J. (2006) · Cell · doi:10.1016/j.cell.2006.06.049 · Cited by 1,015 · cited 1×
“Also supporting this hypothesis is recent evidence coming from anatomical profiling of nuclear receptor expression, showing that MR belongs to a cluster of receptors highly expressed in all tissues and is crucial for maintaining global basal metabolic functions ( 32 ).”
Background
Research works printed but not linked: 1
- 10.1210/mend.13.12.0384 · doi:10.1210/mend.13.12.0384 · Paper page
Cited by
Items 101–200 of 332
Essick, E. E., & Sam, F. (2011) · International Journal of Hypertension · doi:10.4061/2011/346985 · Cited by 47
“Interestingly, aldosterone may in turn promote adipogenesis through its interaction with the mineralocorticoid receptor (MR) [45], and although adipocytes are thought not to synthesize aldosterone, they express the MR [46].”
BackgroundZubiría, M. G., Alzamendi, A., Moreno, G., Rey, M. J., Spinedi, E., & Giovambattista, A. (2016) · Nutrients · doi:10.3390/nu8040198 · Cited by 49
“intake also induced an increase in APCs MR gene expression without any change in that of GR, both receptors being natural mediators of the pro-adipogenic effects of glucocorticoids [34,35].”
BackgroundStrategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone
Pia, A. R., Vignani, F., Attard, G., Tucci, M., Bironzo, P., Scagliotti, G. V., Arlt, W., Terzolo, M., & Berruti, A. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.03.003 · Cited by 47
Fat-brain connections: Adipocyte glucocorticoid control of stress and metabolism
de Kloet, A. D., & Herman, J. P. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.10.005 · Cited by 51
Sayeed, M., Gautam, S., Verma, D. P., Afshan, T., Kumari, T., Srivastava, A. K., & Ghosh, J. K. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001801 · Cited by 45
“25 mol/liter dexamethasone, and 1 mg/liter insulin in DMEM medium with 10% FBS) to differentiate into adipocytes (49).”
Aldosterone, From (Patho)Physiology to Treatment in Cardiovascular and Renal Damage
Waanders, F., de Vries, L. V., van Goor, H., Hillebrands, J., Laverman, G. D., Bakker, S. J. L., & Navis, G. J. (2011) · Current Vascular Pharmacology · doi:10.2174/157016111796642689 · Cited by 43
“Chronic exposure to aldosterone promotes adipogenesis in an MR-dependent manner in vitro [38, 39].”
BackgroundKuzmochka, C., Abdou, H. S., Haché, R. J. G., & Atlas, E. (2014) · Endocrinology · doi:10.1210/en.2014-1565 · Cited by 41
PPARγ in Kidney Physiology and Pathophysiology
Kiss-Tóth, É. D., & Rőszer, T. (2008) · PPAR Research · doi:10.1155/2008/183108 · Cited by 46
“Recent works suggest that aldosterone and mineralocorticoid receptors regulate PPARγ expression [72, 73].”
BackgroundCelastrol: A Promising Agent Fighting against Cardiovascular Diseases
Li, Z., Zhang, J., Duan, X., Zhao, G., & Zhang, M. (2022) · Antioxidants · doi:10.3390/antiox11081597 · Cited by 44
“PPARγ and C/EBPα are two pivotal transcription factors and are closely involved in adipocyte differentiation [42].”
BackgroundCourty, É., Besseiche, A., Do, T. T. H., Liboz, A., Aguid, F. M., Quilichini, E., Buscato, M., Gourdy, P., Gautier, J., Riveline, J., et al. (2018) · Diabetes · doi:10.2337/db17-1314 · Cited by 43
“b-Cell Neogenesis in Mice Treated With CORT and a Mineralocorticoid Receptor Antagonist Because high doses of GCs are able to activate mineralocorticoid receptor (MR) (43), we tested the implication of this receptor.”
BackgroundSelf-citationAnalysis of Insulin Sensitivity in Adipose Tissue of Patients with Primary Aldosteronism
Urbanet, R., Pilon, C., Calcagno, A., Peschechera, A., Hubert, E.-L., Giacchetti, G., Gomez-Sanchez, C., Mulatero, P., Toffanin, M., Sonino, N., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0097 · Cited by 38
“Whereas MR is present in murine preadipocytes and differentiated adipocytes (14), scarce data are available on human adipose tissue (15).”
BackgroundSelf-citationThe mineralocorticoid receptor—an emerging player in metabolic syndrome?
Thuzar, M., & Stowasser, M. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-020-00467-3 · Cited by 39
Hsp90 Blockers Inhibit Adipocyte Differentiation and Fat Mass Accumulation
Desarzens, S., Liao, W.-H., Mammi, C., Caprio, M., & Faresse, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094127 · Cited by 40
Self-citationEnteric Microbiota–Gut–Brain Axis from the Perspective of Nuclear Receptors
Duszka, K., & Wahli, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082210 · Cited by 37
“On the contrary, GR agonists prevent adipogenesis [478,479].”
BackgroundFogari, R., Zoppi, A., Corradi, L., Preti, P. S., Mugellini, A., Lazzari, P., & Derosa, G. (2010) · Hypertension Research · doi:10.1038/hr.2009.220 · Cited by 39
Fernandes-Rosa, F. L., Hubert, E.-L., Fagart, J., Tchitchek, N., Gomes, D. C., Jouanno, E., Benecke, A., Rafestin-Oblin, M. E., Jeunemaı̂tre, X., Antonini, S. R. R., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1486 · Cited by 41
Self-citationInterleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation
Martínez‐Martínez, E., Cachofeiro, V., Rousseau, E., Álvarez, V., Calvier, L., Fernández‐Celis, A., Leroy, C., Miana, M., Jurado-López, R., Briones, A. M., et al. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.04.007 · Cited by 38
“, 2010) and promotes adipogenesis (Briones et al., 2012; Caprio et al., 2007; Rondinone et al., 1993).”
InfluentialLee, N., Kim, I., Park, S., Han, D., Ha, S., Kwon, M., Kim, J., Byun, S.-H., Oh, W., Jeon, H. B., et al. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0130 · Cited by 36
“Because dexamethasone is known to have antiadipogenic effects when added at later stages of adipocyte maturation [26], differentiation was continued on day 4 by switching DMI media to late differentiation media supplemented with 5 m g/mL insulin and 10% FBS and cultured for another 3 days for full…”
Victorio, J. A., Clerici, S. P., Palacios, R., Alonso, M. J., Vassallo, D. V., Jaffe, I. Z., Rossoni, L. V., & Davel, A. P. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07911 · Cited by 37
Shibata, S., & Fujita, T. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.018 · Cited by 39
Cellular mechanisms of MR regulation of adipose tissue physiology and pathophysiology
Armani, A., Marzolla, V., Fabbri, A., & Caprio, M. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0122 · Cited by 36
“At a molecular level, ERK phosphorylates PPARg at serine 273 (Banks et al. 2015).”
BackgroundSelf-citationGlucocorticoid Receptor Signaling Is Not Required for In Vivo Adipogenesis
Bauerle, K. T., Hutson, I., Scheller, E. L., & Harris, C. A. (2018) · Endocrinology · doi:10.1210/en.2018-00118 · Cited by 38
Lee, S.-L., Chin, T., Tu, S.-C., Wang, Y.-J., Hsu, Y., Kao, M., & Wu, Y. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/126302 · Cited by 38
“Conversion of 3T3L1 cells from preadipocytes to adipocytes occurs through treatment with adipogenic agents, including dexamethasone (DEX), isobutylmethylxanthine (IBMX), and insulin [25].”
Su, Y., van der Spek, R., Foppen, E., Kwakkel, J., Fliers, E., & Kalsbeek, A. (2014) · Chronobiology International · doi:10.3109/07420528.2014.963198 · Cited by 35
“Corticosterone is also required for the differentiation of adipocytes, and its stimulatory action on adipocyte differentiation is mediated by the GR or MR (Caprio et al., 2007).”
BackgroundGorini, S., Marzolla, V., Mammi, C., Armani, A., & Caprio, M. (2018) · Biomolecules · doi:10.3390/biom8030096 · Cited by 40
“We first demonstrated that MR expression in murine preadipocytes gradually increases along differentiation, driving the acquisition of the mature adipocyte phenotype via increased expression of peroxisome proliferator-activated receptor-gamma (PPARγ) [96], the “master gene” of adipogenesis in mammals [97].”
BackgroundInfluentialSelf-citationKang, H. S., Lee, J. H., Oh, K., Lee, E., Han, B., Park, K.-Y., Suh, J. M., Min, J., Chi, S., Lee, S. C., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154173 · Cited by 36
Role of Mineralocorticoid Receptor in Adipogenesis and Obesity in Male Mice
Ferguson, D., Hutson, I., Tycksen, E., Pietka, T., Bauerle, K. T., & Harris, C. A. (2019) · Endocrinology · doi:10.1210/endocr/bqz010 · Cited by 39
Hormonal Regulation of Adipogenesis
Lee, M. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160047 · Cited by 50
Mammi, C., Marzolla, V., Armani, A., Feraco, A., Antelmi, A., Maślak, E., Chłopicki, S., Cinti, F., Hunt, H., Fabbri, A., et al. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.13 · Cited by 35
Self-citationTakeda, Y. (2009) · Hypertension Research · doi:10.1038/hr.2009.29 · Cited by 33
Freel, E. M., Tsorlalis, I. K., Lewsey, J., Latini, R., Maggioni, A. P., Solomon, S., Pitt, B., Connell, J., & McMurray, J. J. V. (2009) · Heart · doi:10.1136/hrt.2009.173344 · Cited by 36
“Finally, mineralocorticoid receptors are present on adipoctyes and their activation affects insulin signalling and adipocytokine release.”
BackgroundShibayama, Y., Wada, N., Baba, S., Miyano, Y., Obara, S., Iwasaki, R., Nakajima, H., Sakai, H., Usubuchi, H., Terae, S., et al. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00187 · Cited by 33
“Activation of mineralocorticoid receptor induces the differentiation of preadipocytes to mature adipocytes [28] as well as the expression of proinflammatory genes, such as tumor necrosis factor-a, interleukin-6, and monocyte chemoattractant-1 [29].”
BackgroundFaught, E. L., & Vijayan, M. M. (2019) · The Journal of Physiology · doi:10.1113/jp278088 · Cited by 40
Takeshita, Y., Watanabe, S., Hattori, T., Nagasawa, K., Matsuura, N., Takahashi, K., Murohara, T., & Nagata, K. (2015) · Hypertension Research · doi:10.1038/hr.2015.77 · Cited by 34
Young, M. J., Morgan, J., Brolin, K., Fuller, P. J., & Funder, J. W. (2010) · Endocrinology · doi:10.1210/en.2009-1476 · Cited by 31
Hannich, M. J., Wallaschofski, H., Nauck, M. A., Reincke, M., Adolf, C., Völzke, H., Rettig, R., & Hannemann, A. (2018) · International Journal of Endocrinology · doi:10.1155/2018/4128174 · Cited by 31
Non-Genomic Effects of Aldosterone
Mihailidou, A. S., Tzakos, A. G., & Ashton, A. W. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2018.12.001 · Cited by 31
Even, S., Dulak-Lis, M. G., Touyz, R. M., & Cat, A. N. D. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0013 · Cited by 34
Kim, J., Han, D., Byun, S., Kwon, M., Cho, S., Koh, Y. H., & Yoon, K. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-2948-6 · Cited by 30
Lattin, C., & Romero, L. M. (2015) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2014.05.033 · Cited by 29
Role of mineralocorticoid receptor in insulin resistance
Garg, R., & Adler, G. K. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283533955 · Cited by 35
“These results suggest that mineralocorticoid receptor may be an important proadipogenic transcription factor that may mediate both aldosterone and glucocorticoid effects on adipose tissue development [69].”
BackgroundShen, Y. H., Dai, Y., Wang, X. Q., Zhang, R., Lu, L., Ding, F. H., & Shen, W. F. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0959-1 · Cited by 39
“Adipose tissue is known to produce a lipid-soluble factor that stimulates aldosterone production from the adrenal zona glomerulosa [29, 30].”
BackgroundMoreno‐Navarrete, J. M., & Fernández‐Real, J. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-52031-5_3 · Cited by 44
Mineralocorticoid receptor signalling in primary aldosteronism
Yang, J., Young, M. J., Cole, T. J., & Fuller, P. J. (2023) · Journal of Endocrinology · doi:10.1530/joe-22-0249 · Cited by 29
Kovačević, S., Brkljačić, J. M., Matić, G. M., & Elaković, I. (2014) · European Journal of Nutrition · doi:10.1007/s00394-013-0644-1 · Cited by 33
“MR was described as an important pro-adipogenic transcription factor, since aldosterone promotes acquisition of the adipocyte phenotype by inducing PPARc mRNA [50].”
BackgroundCircadian Clocks and the Interaction between Stress Axis and Adipose Function
Kolbe, I., Dumbell, R., & Oster, H. (2015) · International Journal of Endocrinology · doi:10.1155/2015/693204 · Cited by 30
“Interestingly, glucocorticoids may play a role in adipocyte differentiation via the MR, with knockdown of this receptor, but not GR, inhibiting adipogenesis in the murine 3T3-L1 cell line [33].”
BackgroundSato, A., & Fukuda, S. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2009.81 · Cited by 27
Cardiac effects of aldosterone: Does gender matter?
Mihailidou, A. S., & Ashton, A. W. (2014) · Steroids · doi:10.1016/j.steroids.2014.08.013 · Cited by 28
“been identified in target organs as diverse as the brain [10], vasculature [11], adipose tissue [12], retina [13] and the focus of this”
Resistant Hypertension in the High-Risk Metabolic Patient
Chaudhary, K. R., Buddineni, J. P., Nistala, R., & Whaley‐Connell, A. T. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0155-x · Cited by 27
“There is emerging evidence that adipose tissue produces a lipid-soluble factor that stimulates aldosterone secretion [30].”
BackgroundGEMIN4 functions as a coregulator of the mineralocorticoid receptor
Yang, J., Fuller, P. J., Morgan, J., Shibata, H., Clyne, C. D., & Young, M. J. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0078 · Cited by 30
Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders
Garg, R., & Adler, G. K. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0567-8 · Cited by 27
Su, Y., Foppen, E., Zhang, Z., Fliers, E., & Kalsbeek, A. (2015) · Genes to Cells · doi:10.1111/gtc.12315 · Cited by 29
“According to other studies in mice and rats, PPARa, PPARc, LIPIN1, and MR are important for adipogenesis (Brun et al. 1997; Coleman & Lee 2004; Caprio et al. 2007; Koh et al. 2008; Goto et al. 2011).”
BackgroundGlucocorticoids decrease serum adiponectin level and WAT adiponectin mRNA expression in rats
Shi, J.-H., Du, W.-H., Liu, X., Fan, Y., Hu, X., Zhou, H., Xu, H., Zhang, X., Xiang, P., & Chen, F. (2010) · Steroids · doi:10.1016/j.steroids.2010.05.001 · Cited by 26
Fujii, M., Inoki, I., Saga, M., Morikawa, N., Arakawa, K., Inaba, S., Yoshioka, K., Konoshita, T., & Miyamori, I. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.12.014 · Cited by 25
Zubiría, M. G., Alzamendi, A., Moreno, G., Portales, A. E., Castrogiovanni, D. C., Spinedi, E., & Giovambattista, A. (2016) · Nutrients · doi:10.3390/nu8070410 · Cited by 25
“Notably, expression silencing or activity blocking of MR in both cell types prevent adipogenesis, but this is not the same for GR inactivation [25,26].”
BackgroundÜç, Z. A., Berberoğlu, Z., Görar, S., Candan, Z., Aktas, A., Aral, Y., & Ademoglu, E. N. (2013) · Medical Principles and Practice · doi:10.1159/000351572 · Cited by 25
Jurek, S., Sandhu, M. A., Trappe, S., Bermúdez-Peña, M. C., Kolísek, M., Sponder, G., & Aschenbach, J. R. (2020) · Adipocyte · doi:10.1080/21623945.2020.1720480 · Cited by 27
“However, the use of dexamethasone for extended periods of time and in excessive amounts can be detrimental for ASC induction and differentiation [31].”
BackgroundFaught, E. L., & Vijayan, M. M. (2022) · Endocrinology · doi:10.1210/endocr/bqac149 · Cited by 28
Adipose Tissue Dysfunction in Obesity: Role of Mineralocorticoid Receptor
Parasiliti‐Caprino, M., Bollati, M., Merlo, F. D., Ghigo, E., Maccario, M., & Bo, S. (2022) · Nutrients · doi:10.3390/nu14224735 · Cited by 24
“MR expression has been demonstrated both in BAT and WAT and seems to have a key role in pre-adipocyte differentiation, driving the acquisition of a mature phenotype [51].”
BackgroundBorghi, F., Pessôa, B. S., & Kassisse, D. M. G. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2515-6 · Cited by 25
“Caprio et al. (2007) proved that the MR is also expressed in non-epithelial cells, including adipocytes, confirming the importance of the local RAAS.”
BackgroundImpact of MR on mature adipocytes in high-fat/high-sucrose diet-induced obesity
Hayakawa, T., Minemura, T., Onodera, T., Shin, J., Okuno, Y., Fukuhara, A., Otsuki, M., & Shimomura, I. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0026 · Cited by 25
Eplerenone Implantation Improved Adipose Dysfunction Averting RAAS Activation and Cell Division
Vecchiola, A., Fuentes, C., Solar, I., Lagos, C. F., Opazo, M. C., Muñoz‐Durango, N., Riedel, C. A., Owen, G. I., Kalergis, A. M., & Fardella, C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00223 · Cited by 24
“Preclinical studies have demonstrated that activation of MR works on adipocyte function, resulting in significant changes in biochemical and morphological markers of adipose tissue differentiation (6, 7) positioning MR as a fundamental proadipogenic transcription factor modulating the effects of aldosterone and glucoc…”
BackgroundMinor role of mature adipocyte mineralocorticoid receptor in high-fat diet-induced obesity
Feraco, A., Armani, A., Urbanet, R., Cat, A. N. D., Marzolla, V., Jaisser, F., & Caprio, M. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0314 · Cited by 25
Self-citationYu, S., Ren, J. F., Lv, Z., Li, R., Zhong, Y., Yao, W., & Yuan, J. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.133366 · Cited by 23
Resistant or Refractory Hypertension: Are They Different?
Modolo, R., de Faria, A. P., Almeida, A. R., & Moreno, H. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0485-1 · Cited by 24
De, R., Verma, S. S., Drenos, F., Holzinger, E. R., Holmes, M. V., Hall, M. A., Crosslin, D. R., Carrell, D., Hakonarson, H. H., Jarvik, G. P., et al. (2015) · BioData Mining · doi:10.1186/s13040-015-0074-0 · Cited by 24
“Incidentally, the mineralocorticoid receptor has been shown to play an important role in the positive control of adipogenesis and thus, in the development of obesity [49].”
Adeyanju, O. A., Michael, O. S., Soladoye, A. O., & Olatunji, L. A. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1509220 · Cited by 28
“Studies have shown higher MR mRNA levels in visceral (mesenteric) fat tissue than in subcutaneous fat tissue, suggesting the importance of visceral adiposity in the activation of MR (Caprio et al. 2007, Hirata et al. 2009).”
BackgroundAdipose cell–adrenal interactions: current knowledge and future perspectives
Ronconi, V., Turchi, F., Bujalska, I. J., Giacchetti, G., & Boscaro, M. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.01.004 · Cited by 22
Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats
Youcef, G., Olivier, A., Nicot, N., Muller, A., Deng, C. Z., Labat, C., Fay, R., Guéant‐Rodriguez, R., Leroy, C., Jaisser, F., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13479 · Cited by 21
“…importantly, our findings further demonstrate that the reported reduced adipocyte hypertrophy observed after shorter treatment durations in vivo (Caprio et al., 2007; Hirata et al., 2009) was sustained after 11 months and may account in part for the rarely described reduced weight gain…”
BackgroundResultInfluentialMECHANISMS IN ENDOCRINOLOGY: Brown adipose tissue in humans: regulation and metabolic significance
Thuzar, M., & Ho, K. K. Y. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1217 · Cited by 22
Mineralcorticoid receptor blockers in chronic kidney disease
Erraez, S., López-Mesa, M., & Gómez-Fernández, P. (2021) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2021.08.001 · Cited by 21
Kuhn, E., Bourgeois, C., Keo, V., Viengchareun, S., Muscat, A., Méduri, G., Menuet, D. L., Fève, B., & Lombès, M. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00323.2013 · Cited by 26
“In addition, adipogenesis is known to be associated with an increased expression of important nuclear receptors, including MR (9, 29).”
BackgroundSelf-citationManosroi, W., Phudphong, P., Atthakomol, P., & Phimphilai, M. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01135-y · Cited by 21
“One of the proposed theories is that secretion factors from adipose tissue can stimulate aldosterone secretion, which, in turn, acts on the mineralocorticoid receptor that can mediate adipogenesis [58].”
BackgroundSIMONE, G. D., Chinali, M., Mureddu, G. F., Cacciatore, G., Lucci, D., Latini, R., Masson, S., Vanasia, M., Maggioni, A. P., & Boccanelli, A. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.02.012 · Cited by 20
“Mineralocorticoids levels and activation of mineralocorticoid receptors are increased in the presence of MetS [7], a condition that might be in part responsible for the reported increase in cardiovascular risk in these patients [8,9].”
BackgroundAdipocyte Mineralocorticoid Receptor
Infante, M., Armani, A., Marzolla, V., Fabbri, A., & Caprio, M. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.10.005 · Cited by 21
Self-citationCardiovascular and metabolic characters of KCNJ5 somatic mutations in primary aldosteronism
Chang, Y., Lee, B., Chen, Z., Tsai, C., Chang, C., Liao, C., Pan, C., Peng, K., Chou, C., Lu, C., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1061704 · Cited by 24
“A previous study has reported that aldosterone and mineralocorticoid receptors play an important role in adipose tissue development (104).”
BackgroundLee, M., Pickering, R. T., & Puri, V. (2013) · Obesity · doi:10.1002/oby.20641 · Cited by 20
miRNA-374 Regulates Dexamethasone-induced Differentiation of Primary Cultures of Porcine Adipocytes
Pan, S., Zheng, Y., Zhao, R., & Yang, X. (2013) · Hormone and Metabolic Research · doi:10.1055/s-0033-1334896 · Cited by 19
“Depending on the physiological state, glucocorticoids have been proposed to be both adipogenic and lipolytic in their actions within adipose tissue [ 1 – 5 ] .”
Zubiría, M. G., Vidal‐Bravo, J., Spinedi, E., & Giovambattista, A. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12308 · Cited by 19
“Indeed, when confluent MR-expressing 3T3-L1 cells were induced to differentiate in vitro and then cultured with aldosterone alone, cells enhanced their PPAR-c2 mRNA expression, accumulated lipid and produced adipokines [2].”
BackgroundInfluentialEffects of canrenone in patients with metabolic syndrome
Derosa, G., Bonaventura, A., Bianchi, L., Romano, D., D’Angelo, A., Fogari, E., & Maffioli, P. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.832756 · Cited by 20
“syndrome is diagnosed [6], and this might be in part responsible for the increased cardiovascular risk in these patients [7,8].”
BackgroundEr, L., Lin, M.-C., Tsai, Y., Hsiao, J., Yang, C.-Y., Chang, C., Peng, K., Chueh, S., & Wu, V. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001153 · Cited by 18
Ngo, S., Barry, J. B., Nisbet, J. C., Prins, J. B., & Whitehead, J. P. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.020 · Cited by 17
Caprio, M., Mammi, C., Jaffe, I. Z., Zennaro, M., Aversa, A., Mendelsohn, M. E., Fabbri, A., & Rosano, G. M. C. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786898743 · Cited by 17
“pose tissue [8].”
BackgroundSelf-citationFernandes-Rosa, F. L., Bueno, A. C., de Souza, R. M., de Castro, M., dos Santos, J. E., Foss, M. C., Zennaro, M., Bettiol, H., Barbieri, M. A., & Antonini, S. R. R. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346627 · Cited by 17
Self-citationAldosterone and type 2 diabetes mellitus
Zavatta, G., Casadio, E., Rinaldi, E., Pagotto, U., Pasquali, R., & Vicennati, V. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0065 · Cited by 18
“MR activa tion by glucocorticoids promotes inflammation, oxidative stress, fibrosis, insulin resistance, endothelial dysfunc tion [5, 26–28] and adipocyte differentiation [29].”
BackgroundPacker, M. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.2090 · Cited by 17
Yao, L., Liang, X., & Wang, P. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00022.2023 · Cited by 22
Leachman, J. R., Rea, M. D., Cohn, D. M., Xu, X. Q., Fondufe‐Mittendorf, Y. N., & Loria, A. S. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00243.2020 · Cited by 20
Armani, A., Marzolla, V., Rosano, G. M. C., & Caprio, M. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.68 · Cited by 18
Self-citationZubiría, M. G., Giordano, A. P., Gambaro, S. E., Alzamendi, A., Frontini-López, Y. R., Moreno, G., Spinedi, E., & Giovambattista, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118363 · Cited by 20
Sgk1 Sensitive Pendrin Expression in Murine Platelets
Pelzl, L., Fakhri, H., Umbach, A. T., Gawaz, M., Paulmichl, M., & Lang, F. J. W. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000356640 · Cited by 15
Targeting the mineralocorticoid receptor in cardiovascular disease
Young, M. J. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.748750 · Cited by 15
“However, the range of tissues in which MR have been identified has expanded considerably over recent years to include many non-epithelial tissues including cardiomyocytes, brain, vascular smooth muscle cells (VSMC), adipocytes and monocytes/ macrophages [30-34].”
BackgroundPan, S., Cui, Y., Dong, X., Zhang, T., & Xing, H. (2017) · Oncotarget · doi:10.18632/oncotarget.21318 · Cited by 15
Leachman, J. R., Cincinelli, C., Ahmed, N., Dalmasso, C., Xu, M., Gatineau, E., Nikolajczyk, B. S., Yiannikouris, F. B., Hinds, T. D., & Loria, A. S. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120718 · Cited by 17
Hormone and pharmaceutical regulation of ASP production in 3T3‐L1 adipocytes
Gao, Y., Gauvreau, D., & Cianflone, K. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22464 · Cited by 15
“Hypothetically, this phenomenon could be explained by a switch from a glucocorticoid repressor effect (at low dose) to an activator effect at high dose due to mineralocorticoid receptor driven gene expression in 3T3-L1 adipocytes [Caprio et al., 2007].”
BackgroundVachkova, Е., Bosnakovski, D., Yonkova, P., Григорова, Н., Ivanova, Z., Todorov, P., Penchev, G., Milanova, A., Simeonova, G., Stanilova, S. A., et al. (2016) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-016-0048-7 · Cited by 17
“Furthermore, adding dexamethasone at later stages of adipose maturation has rather adipogenic effects, which is indicative of their strictly time-dependent manner of action (Caprio et al. 2007).”
BackgroundYoucef, G., Olivier, A., L’Huillier, C., Labat, C., Fay, R., Tabcheh, L., Toupance, S., Guéant‐Rodriguez, R., Bergerot, D., Jaisser, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096452 · Cited by 16
“The contribution of each of these metabolic factors in obesity and/or MetS development is well known [25,26], and it is conceivable that their alteration with ageing together with the hyperphagia resulting from the leptin receptor inactivation, participates in the development of the massive obesity and non-alcoholic h…”
BackgroundDOCA Sensitive Pendrin Expression in Kidney, Heart, Lung and Thyroid Tissues
Pelzl, L., Pakladok, T., Pathare, G., Fakhri, H., Michael, D., Wagner, C. A., Paulmichl, M., & Lang, F. J. W. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000343337 · Cited by 15
Bloqueantes del receptor mineralcorticoide en la enfermedad renal crónica
Erraez, S., López-Mesa, M., & Gómez-Fernández, P. (2020) · Nefrología · doi:10.1016/j.nefro.2020.10.001 · Cited by 17
Haas, J., Weber, J., Gonzalez, O., Zimmer, R., & Griffiths, S. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-34241-w · Cited by 18
Metadata
- Authors
- Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., & Zennaro, M.-C.
- Affiliations
- University of Rome Tor Vergata (IT)
- Université Paris-Sud (FR)
- Inserm (FR)
- Corresponding author
- Zennaro, Maria-Christina
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-03-23
- Volume
- 21
- Issue
- 9
- Pages
- 2185-2194
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2020602591
- Semantic Scholar
- 734801b485ad9565f37131d53cbad945c833d55c
- Cited by
- 337
- References
- 37
- Citations by year
- 2026: 10 · 2025: 5 · 2024: 7 · 2023: 13 · 2022: 15 · 2021: 8 · 2020: 18 · 2019: 13 · 2018: 19 · 2017: 20 · 2016: 26 · 2015: 30 · 2014: 36 · 2013: 23 · 2012: 18
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Funders
- Fondation pour la Recherche Médicale
- Institut National de la Santé et de la Recherche Médicale
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- mineralocorticoid receptor, aldosterone, adipogenesis, 3T3-L1 cells, dexamethasone, PPARγ, spironolactone, glucocorticoid receptor, obesity, metabolic syndrome, transcriptional regulation
- MeSH terms
- Aldosterone, Animals, Cell Differentiation, Cells, Cultured, Dexamethasone, Dose-Response Relationship, Drug, Insulin, Male, Obesity, Phenotype, Receptors, Glucocorticoid, RNA, Messenger, Spironolactone, Transcription, Genetic, Receptors, Mineralocorticoid, Metabolic Syndrome, RNA, Small Interfering, Swiss 3T3 Cells, PPAR gamma, Adipogenesis, Mice, Adipose Tissue, White, Adipocytes, White
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.